pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,899 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: pdufa×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa213
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07638800: Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults

    Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Trial Participants

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05955300: Nutrition and Movement to Improve Quality of Life With Knee Osteoarthritis

    Sponsor: St. Pölten University of Applied Sciences. Phase: NA. Conditions: Osteo Arthritis Knee

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07609836: Caudal Dexamethasone - Bupivacaine in Neonates

    Sponsor: Ain Shams University. Phase: NA. Conditions: We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03262636: Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

    Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Brain Tumor, Primary, Brain Tumor, Recurrent

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07349836: Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

    Sponsor: Xinqiao Hospital of Chongqing. Phase: EARLY_PHASE1. Conditions: EBV-associated Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07583836: DELAYED VERSUS EARLY SURGICAL DECOMPRESSION FOR TRAUMATIC SPINAL CORD INJURY

    Sponsor: Fauji Foundation Hospital. Phase: . Conditions: Traumatic Spinal Cord Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07367971: Drug-Drug Interaction Study of ABP-671 in Gout Patients

    Sponsor: Atom Therapeutics Co., Ltd. Phase: PHASE1. Conditions: Gout Chronic, Gout, DDI (Drug-Drug Interaction)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07380334: A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

    Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06777134: Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients

    Sponsor: Berivan Beril Kılıç. Phase: . Conditions: Multiple Sclerosis, Pelvic Floor Dysfunction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07568509: Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

    Sponsor: Massachusetts General Hospital. Phase: EARLY_PHASE1. Conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, Hypopituitarism

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07004699: Comparison of Two Ventilation Methods During Endoscopy of the Pharynx, Larynx and Oesophagus

    Sponsor: Poitiers University Hospital. Phase: NA. Conditions: Oxygen Inhalation Therapy Endoscopy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05553132: A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects

    Sponsor: Daniel B. F. Saris. Phase: PHASE1. Conditions: Cartilage Defect

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07640932: Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer

    Sponsor: Yonsei University. Phase: PHASE2. Conditions: Carcinoma, Small Cell Lung

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06216132: Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults

    Sponsor: Akyso Therapeutics, LLC. Phase: PHASE1. Conditions: Opioid Use Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06438263: A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

    Sponsor: Amgen. Phase: PHASE1. Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06011187: Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Decision Support System, Outcome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01073787: Intravenous Fluid for Pediatric Migraine in the Emergency Department

    Sponsor: University of Alberta. Phase: PHASE1. Conditions: Migraine, Headache

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03575221: Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation

    Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Osteogenesis Imperfecta, Short Stature

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07616193: Interaction Between Spasticity and the Initial Response After Balance Perturbations in Children With Spastic Cerebral Palsy

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: . Conditions: Cerebral Palsy (CP), Typically Developing Children

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06015893: Semaglutide Therapy for Alcohol Reduction (STAR)

    Sponsor: National Institute on Drug Abuse (NIDA). Phase: PHASE2. Conditions: Addiction, Alcohol Use Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04936620: Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling

    Sponsor: St George's, University of London. Phase: NA. Conditions: Spinal Cord Injuries

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07092982: Comparison of Two Different Regional Anesthetic Methods in Total Knee Arthroplasty Patients

    Sponsor: SB Istanbul Education and Research Hospital. Phase: NA. Conditions: Total Knee Arthroplasty, Ultrasound Guided Supra-inguinal Fascia Iliaca Block, Adductor Canal Block

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06630780: Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma

    Sponsor: Sun Yat-sen University. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06104280: Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment

    Sponsor: University of Alabama at Birmingham. Phase: . Conditions: Opioid Use Disorder, Sleep Disturbance

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07647380: TIS for Improving Cognitive Impairment in Schizophrenia

    Sponsor: Central South University. Phase: NA. Conditions: Schizophrenia Disorder, Cognitive Impairments

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04443062: Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer

    Sponsor: Radboud University Medical Center. Phase: PHASE2. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07477262: Health Effects of a Walking Program in a High-Quality Tourism Environment for Older Women

    Sponsor: Yu-fan Li. Phase: NA. Conditions: Overweight , Obesity

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01999062: Automated Breast Radiation Therapy Using an MR-Guided Process

    Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02866162: Screening for Genes in Patients With Congenital Neutropenia

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Congenital Neutropenia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07443761: Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital.

    Sponsor: University Hospital, Antwerp. Phase: . Conditions: Benign Pancreas Tumor, Malignant Pancreatic Neoplasm

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07047261: Efficacy of a Xanthan-based Chlorhexidine Gel in the Treatment of Peri-implant Mucositis

    Sponsor: University of Turin, Italy. Phase: NA. Conditions: Peri-implant Mucositis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06459986: The Duration of Spinal Anaesthesia - a Prospective, Observational Cohort Study

    Sponsor: Nordsjaellands Hospital. Phase: . Conditions: Orthopedic Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07316270: SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracerebral Hemorrhage (SAFER-AF)

    Sponsor: Beijing Anzhen Hospital. Phase: NA. Conditions: AF - Atrial Fibrillation, ICH - Intracerebral Hemorrhage

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02410473: Evaluation of Coagulation Testing in Patients Undergoing Cardiac Surgery

    Sponsor: Boston Children's Hospital. Phase: . Conditions: Congenital Heart Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06318169: A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

    Sponsor: 89bio, Inc.. Phase: PHASE3. Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07110441: Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers

    Sponsor: Genfit. Phase: PHASE1. Conditions: Acute-on-Chronic Liver Failure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07607054: A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

    Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Locally Advanced or Metastatic Solid Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06482905: Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

    Sponsor: Tcelltech Inc.. Phase: PHASE1. Conditions: High-grade Glioma, WHO Grade Ⅳ Glioma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03552705: The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients

    Sponsor: Stanford University. Phase: PHASE2. Conditions: Anterior Cruciate Ligament Reconstruction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07483294: Cerebellum-based Imaging Neural Markers for Antipsychotic Response

    Sponsor: Northwell Health. Phase: PHASE4. Conditions: Psychosis; Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07335666: Virtual Reality Outperforms Game Card Distraction in Reducing Distress During Pediatric Wound Care

    Sponsor: Agri Ibrahim Cecen University. Phase: NA. Conditions: Pediatric Wounds, Procedural Pain, Procedure-Related Anxiety, Procedural Fear

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05403151: Controls and Healthy Vasculature Initiative

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Vascular And Immunologic Diseases, Healthy Volunteers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06493851: The Effect of Hyperbaric Oxygen Therapy for Acceleration Recovery After Anterior Cruciate Ligament Reconstruction(ACLR)

    Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Anterior Cruciate Ligament Reconstruction

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06779851: A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors

    Sponsor: Bright Peak Therapeutics Inc. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05860751: The Effect of Dry Needling With Electrical Stimulation on Individuals With Restless Legs Syndrome

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Neck Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05794451: Developing an Artificial Intelligence System to Detect Cognitive Impairment

    Sponsor: University of Haifa. Phase: . Conditions: Alzheimer Disease, Healthy Aging, Mild Cognitive Impairment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00337051: Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)

    Sponsor: University Hospital, Bordeaux. Phase: PHASE3. Conditions: End-stage Chronic Renal Disease, Severe Acute Kidney Failure, Renal Transplantation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03390751: Atropine Weight and Risk of Postoperative Confusion in the Elderly

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Aging

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07225751: A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

    Sponsor: Kuros Biosurgery AG. Phase: NA. Conditions: Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion, Ankle Deformity, Ankle Disease, Hindfoot Arthrodesis, Hindfoot Pathologies

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06448351: Manipulating E-Cigarette Nicotine to Promote Public Health

    Sponsor: Ohio State University Comprehensive Cancer Center. Phase: NA. Conditions: Tobacco-Related Carcinoma

    full page →ctgov ↗
    ← prev
    page 64 of 98
    next →